The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-22-001 |
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) |
93.394 |
PAR-22-071 |
Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) |
93.113, 93.121, 93.242, 93.307, 93.393, 93.395, 93.396 |
PAR-22-072 |
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed) |
93.084, 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.307, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93 |
PAR-22-073 |
Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Data Coordinating Center (DCC) (U24 Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840, 93.853 |
RFA-NS-22-013 |
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) |
93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.867 |
PAR-21-343 |
Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed) |
93.242 |
PAR-22-067 |
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-23-009 |
Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Clinical Coordinating Center (CCC) (U24 Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840, 93.853 |
RFA-NS-22-014 |
Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) |
93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.867 |
PAR-21-342 |
Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Network Clinical Center (Hub) (U24 Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840, 93.853 |
RFA-NS-22-015 |
Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed) |
93.242, 93.273, 93.279, 93.866 |
PAR-22-032 |
Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed) |
93.242 |
PAR-22-066 |
Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-22-006 |
NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional) |
93.242, 93.279, 93.866 |
RFA-DA-22-036 |
Age-related Macular Degeneration (AMD) Integrative Biology Initiative: Discovery of AMD Pathobiology using Patient-Derived Induced Pluripotent Stem Cell (iPSC)-derived Retinal Pigment Epithelium (RPE) (U01 Clinical |
93.867 |
RFA-EY-21-002 |
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) |
93.173, 93.307, 93.313, 93.846 |
PAR-22-064 |
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) |
93.233, 93.350, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-23-008 |
HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) |
93.121, 93.213, 93.286, 93.313, 93.350, 93.846, 93.853, 93.865, 93.866 |
RFA-AT-22-003 |
Understanding Place-Based Health Inequalities in Mid-Life (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-23-004 |
Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required) |
93.242 |
RFA-MH-22-150 |
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) |
93.866 |
PAR-22-047 |
Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed) |
93.853 |
PAR-22-055 |
NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) |
93.867 |
PAR-22-070 |
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) |
93.865 |
PAR-21-353 |
Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed) |
93.853 |
PAR-22-028 |
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional) |
93.865 |
PAR-21-354 |
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) |
93.865 |
PAR-21-355 |
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) |
93.853 |
PAR-22-030 |
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) |
93.398 |
RFA-CA-21-060 |
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) |
93.398 |
RFA-CA-21-061 |
Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-026 |
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) |
93.398 |
RFA-CA-21-062 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-22-004 |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-22-003 |
RePORT International Coordinating Center (RICC) (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-078 |
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) |
93.393, 93.396 |
PAR-22-061 |
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) |
93.393, 93.396 |
PAR-22-062 |
Prodromal Synaptic and Circuit Changes that Contribute to AD/ADRD Onset and Progression (R01 Clinical Trial Not Allowed) |
93.853, 93.866 |
PAR-22-059 |
Limited Competition: Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed) |
93.233, 93.351, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.867 |
PAR-22-056 |
Search Results 1721-1760 of 14606 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |